Indeed, melanoma-specific CD133+ isolated cancer stem cells exhibit increased stem cell markers, such as NANOG and Oct3/4, and possess tumor-initiating potential, compared to CD133- cells (Kumar et al., 2016). This evidence concerns the gene PROM1 and melanoma.